Additionally, UBE2N promotes the ubiquitination and degradation of Axin1, and the overexpression of Axin1 negates the effects of UBE2N on the viability and glycolysis of prostate cancer cells (Yang et al., 2024). This evidence concerns the gene AXIN1 and prostate carcinoma.